Vanda Pharmaceuticals Inc (VNDA)
5.36
-0.11
(-2.01%)
USD |
NASDAQ |
May 08, 16:00
5.05
-0.31
(-5.78%)
After-Hours: 19:30
Vanda Pharmaceuticals Free Cash Flow: 12.42M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.42M |
| September 30, 2023 | 25.56M |
| June 30, 2023 | 40.32M |
| March 31, 2023 | 59.09M |
| December 31, 2022 | 31.30M |
| September 30, 2022 | 48.62M |
| June 30, 2022 | 45.34M |
| March 31, 2022 | 58.57M |
| December 31, 2021 | 63.66M |
| September 30, 2021 | 55.52M |
| June 30, 2021 | 55.25M |
| March 31, 2021 | 60.32M |
| December 31, 2020 | 49.98M |
| September 30, 2020 | 41.37M |
| June 30, 2020 | 37.94M |
| March 31, 2020 | 34.40M |
| December 31, 2019 | 44.93M |
| September 30, 2019 | 50.45M |
| June 30, 2019 | 53.30M |
| March 31, 2019 | 12.36M |
| December 31, 2018 | 4.618M |
| September 30, 2018 | -7.348M |
| June 30, 2018 | -14.11M |
| March 31, 2018 | 3.691M |
| December 31, 2017 | -3.647M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.802M |
| June 30, 2017 | -9.957M |
| March 31, 2017 | -10.45M |
| December 31, 2016 | -9.51M |
| September 30, 2016 | -8.70M |
| June 30, 2016 | -15.07M |
| March 31, 2016 | 0.251M |
| December 31, 2015 | 9.922M |
| September 30, 2015 | -2.732M |
| June 30, 2015 | -4.659M |
| March 31, 2015 | -53.51M |
| December 31, 2014 | -90.32M |
| September 30, 2014 | -88.85M |
| June 30, 2014 | -91.48M |
| March 31, 2014 | -62.66M |
| December 31, 2013 | -39.77M |
| September 30, 2013 | -41.37M |
| June 30, 2013 | -41.28M |
| March 31, 2013 | -45.55M |
| December 31, 2012 | -46.93M |
| September 30, 2012 | -45.51M |
| June 30, 2012 | -42.54M |
| March 31, 2012 | -35.96M |
| December 31, 2011 | -28.68M |
| September 30, 2011 | -21.35M |
Free Cash Flow Range, Past 5 Years
12.42M
Minimum
Dec 2023
63.66M
Maximum
Dec 2021
45.70M
Average
48.62M
Median
Sep 2022
Free Cash Flow Benchmarks
| ADMA Biologics Inc | 3.819M |
| INVO Bioscience Inc | -5.200M |
| Johnson & Johnson | 18.23B |
| Nektar Therapeutics | -193.47M |
| Invivyd Inc | -173.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.732M |
| Cash from Investing (Quarterly) | -43.78M |
| Free Cash Flow Per Share (Quarterly) | -0.0691 |
| Free Cash Flow to Equity (Quarterly) | -3.985M |
| Free Cash Flow to Firm (Quarterly) | -3.985M |
| Free Cash Flow Yield | 4.03% |